Psychiatr. praxi. 2016;17(3):112-114

Studie VIVALDI (Valdoxan Improves Depressive Symptoms and Normalizes Circadian Rhythms)

prof. MUDr. Pavel Mohr, Ph.D.,
Národní ústav duševního zdraví, Klecany

Gerd Laux, Nadja Huttner & studijní skupina VIVALDI: Analýza podskupin

neintervenční studie VIVALDI: Agomelatin u dříve neléčených pacientů,

v kombinované léčbě a po změně léčby. International Journal of Psychiatry

in Clinical Practice 2014; 18: 86–96.

Published: October 26, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mohr P. Studie VIVALDI (Valdoxan Improves Depressive Symptoms and Normalizes Circadian Rhythms). Psychiatr. praxi. 2016;17(3):112-114.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Laux G, VIVALDI Study Group.The antidepressant agomelatine in daily practice: results of the non-interventional study VIVALDI. Pharmacopsychiatry 2012; 45: 284-291. Go to original source... Go to PubMed...
    2. Laux G, Huttner NA & VIVALDI study group: Subgroup analysis of the non-interventional study VIVALDI: agomelatine in treatment-na?ve patients, in combination therapy and after treatment switch. Int J Psychiatry Clin Pract 2014; 18: 86-96. Go to original source... Go to PubMed...
    3. MacIsaac SE, et al. The mechanizm, efficacy, and tolerability profile of agomelatine. Expert Opin Pharmacother 2014; 15: 259-274. Go to original source... Go to PubMed...
    4. Švestka J, Mohr P. Agomelatin - antidepresivum s novým mechanismem působení. Psychiatrie 2010; 14: 98-108.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.